Skip to content
Oddify Resources offers a curated collection of unique tool…

The Zimbabwean Government Turns Down ‘Unbalanced’ American Health Aid Deal Because of Information Fears

Medical aid image
The proposed US funding was aimed at programmes for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has rejected a significant US health deal worth 367 million US dollars (£272m) spanning five years because of Washington's request for sensitive data.

The decision came to light after a government memo dated December was leaked, which showed Head of State Emmerson Mnangagwa felt the agreement was "lopsided".

An official spokesman later clarified that the US was seeking biological samples for research and commercial purposes but was not willing to share the benefits from any future treatments.

"We will now turn to the challenging and unfortunate process of scaling back our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy said the US had donated over $1.9bn for health programmes to Zimbabwe during the past two decades.

A doctors' association in Zimbabwe has appealed for more negotiations to reach a agreement agreeable to all parties so the country's vital HIV programme can continue.

Broader Background

Zimbabwe's decision follows a similar situation in Kenya, where a high court blocked a similar health funding agreement after legal challenges were filed about the security of Kenyans' health data.

Since returning to office last year, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).

The agency had managed aid for the US government, but Trump argued its spending was "wasteful" and his government was pursuing direct bilateral deals to boost openness and responsibility.

As per reports, 16 nations in Africa have to date agreed to these new agreements, constituting over $18.3bn in committed funds.

Specifics of the Rejected Deal

The funds for Zimbabwe was intended to funded "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"It is our view this cooperation could have provided extraordinary benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently on HIV treatment via US-supported programmes," the Ambassador commented.

However, official spokesman Nick Mangwana said the arrangement was "unfair".

"Our nation was requested to share its biological resources and data over an extended period, with no corresponding promise of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," he stated.

"Effectively, our nation would supply the raw materials for medical research with no assurance that the end products would be accessible to our people should a new health crisis emerge."

Sovereignty and Global Health

He also said that the American exit from the global health body and its pursuit of bilateral health agreements were undermining structures previously set up through the global organization.

Mangwana cited its Pandemic Benefit-Sharing scheme created to deal with future global health emergencies.

"This framework is intended to guarantee that when a nation contributes its information, the benefits – including medicines and cures – are distributed fairly, not commercialised solely by those with the resources to develop them."

The government's concerns over the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.

"We are open to continued dialogue with our US partners on how subsequent co-operation could be structured in a manner that honours the sovereignty and dignity of each country."

Health Experts Response

A leading public health body expressed it acknowledged the government's concerns, but recommended that negotiations need to persist considering much of the nation's HIV programmes depended on external financing.

"If specific concerns arise, including those relating to information security or implementation frameworks, these can often be resolved through detailed discussion and negotiated safeguards," the group said.

This impasse emphasises the ongoing challenges between accepting crucial international aid and safeguarding national sovereignty in an ever more data-driven world.

TS
About the author

Tiffany Santana

A tech innovator and creative strategist with over a decade of experience in developing unconventional solutions for modern challenges.

Oddify Resources

Type to search articles.